Stay updated on Cabozantinib in Pancreatic Neuroendocrine & Carcinoid Tumors Clinical Trial
Sign up to get notified when there's something new on the Cabozantinib in Pancreatic Neuroendocrine & Carcinoid Tumors Clinical Trial page.

Latest updates to the Cabozantinib in Pancreatic Neuroendocrine & Carcinoid Tumors Clinical Trial page
- Check5 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedA new page revision tag v3.6.3 was added, replacing v3.6.2. This indicates a small version update to the page's metadata and documentation.SummaryDifference0.1%

- Check27 days agoChange DetectedPage revision updated from v3.6.0 to v3.6.2, indicating a newer version of the page's content or code. This update largely reflects internal maintenance and does not alter the study details or displayed information.SummaryDifference0.1%

- Check41 days agoChange DetectedThe page now indicates recruitment is closed, signaling no participant enrollment. It also adds new help/navigation sections (How to Read a Study Record, Common Questions, How to Join a Study), updates the revision label to v3.6.0, and adjusts the Intervention/Treatment header formatting.SummaryDifference0.4%

- Check49 days agoChange DetectedThe page revision label was updated from v3.5.4 to v3.5.5, indicating a newer version of the page is now live. This appears to be a metadata/maintenance update rather than a substantive change to the study details.SummaryDifference0.1%

- Check70 days agoChange DetectedThe page revision label updated from v3.5.3 to v3.5.4, indicating a minor update to the page framework without changes to study content.SummaryDifference0.1%

- Check91 days agoChange DetectedThe page footer revision label was updated from **v3.5.2** to **v3.5.3**, indicating a minor ClinicalTrials.gov site release.SummaryDifference0.1%

Stay in the know with updates to Cabozantinib in Pancreatic Neuroendocrine & Carcinoid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cabozantinib in Pancreatic Neuroendocrine & Carcinoid Tumors Clinical Trial page.